You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market
- 2. Kexing Biopharm's New Cancer Drug Gets Peru Market Approval
- 3. Early prediction of colorectal adenoma risk: leveraging large-language model for clinical electronic medical record data
- 4. IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis
- 5. Cuproptosis as a therapeutic target in cancer: a Systematic Review and bibliometric analysis of the research landscape
- 6. Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer
- 7. NIH researchers discover tissue biomarker that may indicate higher risk of aggressive breast cancer development and death
- 8. Visualising the mechanics of hormone-driven gene activation: Insights into breast cancer
- 9. Synchronous papillary renal neoplasm with reverse polarity and membranous nephropathy: a rare case report
- 10. A simple approach to prevent skin damage from heat steam in robotic breast surgery
Last updated at 11:46 GMT
Hot News Makers
Health/Pharma Companies
-
10477.59
-
7369.19
-
3433.14
-
3320.81
-
2766.05
-
2116.56
-
1349.93
-
1274.82
-
845.51
-
716.88
Drugs, Treatments, Trials
-
2958.35
-
2218.76
-
1357.62
-
524.29
-
496.79
-
354.41
-
192.54
-
132.90
-
112.08
-
106.32
Last updated at 11:10 GMT
